Professor Kelly-Anne Phillips is a Consultant Medical Oncologist, and Co-Lead of Breast Medical Oncology at the Peter MacCallum Cancer Centre. She is an Honorary Professorial Fellow at The University of Melbourne, an NHMRC Leadership Fellow, and a Fellow of the Australian Academy of Health and Medical Sciences. In 2025 she was inducted into the Victorian Women’s Honour Roll for her contributions to breast cancer prevention and treatment, recognising work that has helped shape clinical practice and health policy.  

Professor Phillips is a leader in developing digital health innovations and clinical services for precision breast cancer prevention. She established Australia’s first Breast and Ovarian Cancer Risk Management Clinic and led development of iPrevent, an evidence-based breast cancer risk assessment and decision support tool now recommended by national health bodies. She also founded the Preventing Cancer with Medications (PCMed) Telehealth Service to support informed decision-making about medications that halve breast cancer risk.

Her research leadership spans several practice-changing clinical trials, including the POEMS study, which demonstrate that goserelin reduces chemotherapy-induced menopause and infertility, and the OlympiA study, which showed that adjuvant olaparib improves survival for people with BRCA1/2-associated breast cancer. She has also led studies clarifying the cognitive effects of anti-hormone therapies and has directed the kConFab Follow-Up Study since 2001, generating longitudinal data that continue to inform understanding of breast cancer risk. She ranks among the top 2% of most cited researchers globally in her field.  

Professor Phillips chaired the Prevention Group of the 2024 Lancet Breast Cancer Commission and serves as an Associate Editor of the Journal of the National Cancer Institute. She has contributed to international and national guidelines and was senior author of the influential 2023 ASCO Research Statement on measuring ovarian toxicity in clinical trials.

An outcome-focussed clinician-scientist, Professor Phillips is committed to ensuring that high quality research is translated into policy and practice. Her research and advocacy have been central to improving equitable access to breast cancer prevention agents and treatments that improve outcomes for Australian women.